Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Tranexamic acid manufacturers

Filters

Filters

Filters , active

Country of origin : Italy

Clear all

None products found
Differentiated form and dose

tranexamic acid

Solution for infusion 10 mg/ml; 5 mg/ml - 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
United States
Registered in
Portugal
Available for
Licensing with supply, Distribution only, Technology transfer
Comments
Added value Tranexamic acid solution for infusion 10 mg/ml 100 ml Tranexamic acid in NaCl.
Manufacturer #25062

Established in 2005, this manufacturer is a leading CTD dossier owner and manufacturer, operating globally across multiple regions. It employs a robust team dedicated to GMP manufacturer standards, with GMP approvals in various countries. Their products, developed by an expert CTD dossier owner and manufacturer, are sold in over 50 countries. The manufacturer boasts advanced production lines designed for both GMP manufacturer processes and CTD dossier requirements. This ensures high-quality pharmaceutical production and compliance as a CTD dossier owner and manufacturer.

Manufacturer usually replies in 6 days

tranexamic acid

Ampoules, injection 500 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17477
A pharmaceutical manufacturer based in the EU that has partnerships with global pharmaceutical companies worldwide for 90+ years. The company's main therapeutic areas include anesthesia, cardiology, and infectivology. The manufacturing facilities are GMP approved and its activities for FDF and API are FDA approved.

Manufacturer usually replies in 35 days

Differentiated form - Oral Solution

tranexamic acid

Oral solution 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
This product is registered in European Union.
Manufacturer #17047

A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 18 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Tranexamic acid is a coagulation modifier class medication that is used to prevent blood loss after major trauma, factor IX deficiency, hemophilia type A, melasma, nosebleeds, menorrhagia, and menstrual disorders. Manufacturing companies produce it as both standalone medication and in combination drug formulations, along with ingredients such as etamsylate and mefenamic acid. Suppliers market it in the forms of 100mg/ml solution for intravenous injection and 500mg tablets. In use for over 50 years, tranexamic acid is an inexpensive and widely used treatment. The World Health Organisation has included it in its list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Major pharmaceutical manufacturers and supplies of tranexamic acid include Pfizer and Sanofi-Aventis. Tranexamic acid is available in both trade name and generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.